- New essential Guide to Prescription Drugs, Update on Alcohol communicates author concerns
- MADD Report to the nation on drunk driving
- Long hours at work and just one drink or something else and risky alcohol use?
- Breast cancer and traztuzumab plus neratinib target drug therapy hope
- Could a PCSK9 inhibitor treat YOUR cholesterol soon?
- Metformin, a diabetes drug in Lake Michigan?
- Stroke risk and hidden or undiagnosed diabetes
- Opana and other Extented Release or Long Acting opioids now have a REMS-what on earth does that mean?
- New monoclonal antibody to PCSK9 in Lipitor patients and possible 70% decrease in bad cholesterol ???
- Remembering that alcohol (ethanol) IS a drug
- Benefit to risk decisions, consideration of Qnexa and involving your doctor
- A potential new weapon to stop our fat attacks called Qnexa (phentermine plus topiramate)
- From DSM 4 to 5: Will lower diagnostic thresholds lead to overmedication in Psychiatry ??
- Heartburn medicines (Nexium to Prilosec and back) and serious diarrhea
- Lipitor going generic as atorvastatin
- Intermezzo for those who wake up and can't get back to sleep
- Aetna to provide some low cost or free drugs to patients after a heart attack
- Yervoy rejected by NICE, but what about the patients?
- Two diseases treated with one pill (Juvisync-sitagliptin, simvastatin) ?
- 148 million dollar bill for Medicare drug abuse ???
- Cancer and OHOP--FDA reorganizes drug division
- FDA requires label changes for Tumor Necrosis Factor blockers for Rheumatoid Arthritis and Crohn's based on infection risks
- NSAIDS during pregnancy and miscarriage risk
- Celexa (citalopram) more than 40 mg risky for your heart
- Zelboraf (vemurafenib)--New hope in melanoma or combination therapy option?
- Drug Interactions in the news and Zyvox (linezolid), methylene blue and a variety of psychiatric medicines
- Will YOU get the flu this year ???
- Yervoy (ipilimumab) and MDX 1106 (BMS-936558), a new investigational combination (NCT 01024231) in a previously abysmal metastatic melanoma battlefield
- Freedom from pain? IOM has a blueprint for transformation
- Yervoy (ipilimumab) abstracts and valuable new information
- Eloquent efficacy for Eliquis in atrial fibrillation patients
- Lipitor, Zocor, Pravachol and dose related side effects, and diabetes and what to do
- FDA's new plan for opioid misuse
- Knowing YOUR Family Cholesterol History
- The new Guideline Advantage
- What on earth do those words mean?
- Pradaxa promise revealed in new atrial fibrillation (afib) guidelines
- Time is brain--ask for quick treatment if you think you are having a stroke
- Daily Diet Soda Associated With 61 % higher risk of blood vessel (vascular) events
- Where's the beef? FDA rejects Contrave combination of two FDA approved medicines
- Breast implants associated with rare lymphoma
- Substantially equivalent reviews for tobacco products
- FDA Fails or FDA Failed to be supported?
- FDA: Stop taking and throw away Fruta Planta
- Denosumab: One drug with two names that treats osteoporosis and delays cancer spread to bones
- Expanded access and getting clincial trial medicines
- Weight worries and lead your family
- Yervoy (ipilimumab) melanoma immune-based therapy at FDA Feb 9, 2011
- Contrave and long wait for a new weight loss drug is probably over
- New blood thinner study in the news again
- Kindle your interest in The Essential Guide to Prescription Drugs
- Long wait for weight loss at the FDA
- Four Loko, Joose, Core High Gravity (HG, orange), Lemon Lime Core Spiked no longer to be shipped
- One pill and at least two benefits
- Blood thinners for beginners
- Breakthrough at AHA-CETP inhibitor born and to be researched for cholesterol therapy
- Exuberance in Chicago at the EMPHASIS HF results for heart failure patients
- Putting the EMPHASIS on heart failure in Chicago
- Small doses of change from the American Heart Association meeting in Chicago
- Riding a ROCKET for atrial fibrillation and stroke and embolism prevention
- Ipilimumab review delayed but shows promise for melanoma
- Contrave may join weight loss weapons in December
- Exciting new cholesterol treatment approach
- TJC and hospital quality for your family
- Cymbalta in chronic pain and possible combinations
- Cholesterol puzzles: Apolipoprotein A1 and investigational anacetrapib
- FDA Findings...when drugs break bad
-
Diabetes dilemmas, a small dose for you (click here)